BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27404875)

  • 1. Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.
    Sarangdhar M; Tabar S; Schmidt C; Kushwaha A; Shah K; Dahlquist JE; Jegga AG; Aronow BJ
    Nat Biotechnol; 2016 Jul; 34(7):697-700. PubMed ID: 27404875
    [No Abstract]   [Full Text] [Related]  

  • 2. Human factors and medical IT systems: complex incident reporting systems and multiple IV infusions.
    Colvin C; Baird P; Easty T; Trbovich P
    Biomed Instrum Technol; 2013; Suppl():59-63. PubMed ID: 24111773
    [No Abstract]   [Full Text] [Related]  

  • 3. AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System.
    Grigoriev I; zu Castell W; Tsvetkov P; Antonov AV
    Pharmacoepidemiol Drug Saf; 2014 Aug; 23(8):795-801. PubMed ID: 24677538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A visual-interactive system for prostate cancer cohort analysis.
    Bernard J; Sessler D; May T; Schlomm T; Pehrke D; Kohlhammer J
    IEEE Comput Graph Appl; 2015; 35(3):44-55. PubMed ID: 26010788
    [No Abstract]   [Full Text] [Related]  

  • 6. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
    Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
    J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
    Trifirò G; Patadia V; Schuemie MJ; Coloma PM; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Scotti L; Pedersen L; Avillach P; Sturkenboom MC; van der Lei J; Eu-Adr Group
    Stud Health Technol Inform; 2011; 166():25-30. PubMed ID: 21685607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's sentinel network: a monumental task.
    Young D
    Am J Health Syst Pharm; 2007 Apr; 64(8):800-1. PubMed ID: 17420189
    [No Abstract]   [Full Text] [Related]  

  • 9. Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records.
    Banda JM; Callahan A; Winnenburg R; Strasberg HR; Cami A; Reis BY; Vilar S; Hripcsak G; Dumontier M; Shah NH
    Drug Saf; 2016 Jan; 39(1):45-57. PubMed ID: 26446143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits of data mining.
    Bone A; Houck K
    Elife; 2017 Aug; 6():. PubMed ID: 28813246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benefits of large healthcare databases for drug risk research].
    Garbe E; Pigeot I
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Aug; 58(8):829-837. PubMed ID: 26092163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trivalent Influenza Vaccine Adverse Event Analysis Based On MedDRA System Organ Classes Using VAERS Data.
    Tao C; Du J; Cai Y; Chen Y
    Stud Health Technol Inform; 2015; 216():1076. PubMed ID: 26262375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on "Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting" by Linder et al.
    Dal Pan GJ
    Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1216-7. PubMed ID: 20981885
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Extreme duplication' in the US FDA Adverse Events Reporting System database.
    Hauben M; Reich L; DeMicco J; Kim K
    Drug Saf; 2007; 30(6):551-4. PubMed ID: 17536881
    [No Abstract]   [Full Text] [Related]  

  • 15. Pediatric post-marketing safety systems in North America: assessment of the current status.
    McMahon AW; Wharton GT; Bonnel R; DeCelle M; Swank K; Testoni D; Cope JU; Smith PB; Wu E; Murphy MD
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):785-92. PubMed ID: 26098297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automatic detection of adverse events to predict drug label changes using text and data mining techniques.
    Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientists mine web search data to identify epidemics and adverse events.
    Kuehn BM
    JAMA; 2013 May; 309(18):1883-4. PubMed ID: 23652502
    [No Abstract]   [Full Text] [Related]  

  • 18. Pediatric drug safety signal detection: a new drug-event reference set for performance testing of data-mining methods and systems.
    Osokogu OU; Fregonese F; Ferrajolo C; Verhamme K; de Bie S; 't Jong G; Catapano M; Weibel D; Kaguelidou F; Bramer WM; Hsia Y; Wong IC; Gazarian M; Bonhoeffer J; Sturkenboom M
    Drug Saf; 2015 Feb; 38(2):207-17. PubMed ID: 25663078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov.
    Su EW
    Methods Mol Biol; 2019; 1903():61-72. PubMed ID: 30547436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mini-Sentinel and regulatory science--big data rendered fit and functional.
    Psaty BM; Breckenridge AM
    N Engl J Med; 2014 Jun; 370(23):2165-7. PubMed ID: 24897081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.